Navigation Links
Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain
Date:11/28/2008

that the product will receive regulatory approval for chronic pain, or that it will continue to be commercially successful. For further discussion of these and other risks and uncertainties, see Lilly's filings with the United States Securities and Exchange Commission. Lilly undertakes no duty to update forward-looking statements.

    (i)    Chappell, A. et al. Duloxetine 60 to 120 mg versus Placebo in the
           Treatment of Patients with Osteoarthritis Knee Pain. Poster
           presented at the European League Against Rheumatism. 13 June 2008.
    (ii)   Skljarevski, V. et al. Efficacy of Duloxetine in Chronic Low Back
           Pain.  Poster presented at the European Federation of Neurological
           Societies Annual Congress. 25 August 2008.
    (iii)  Skljarevski, V. et al. Duloxetine versus Placebo in the Treatment
           of Chronic Low Back Pain.  Poster presented at the 12th World
           Congress of Pain. 21 August 2008.
    (iv)   APF 2008.
    (v)    NIH 1998.
    (vi)   Fox et al. 2000.
    (vii)  Stewart et al. 2003.
    (viii) White et al. 2005.

    (Logo:http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO )


'/>"/>
SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Daiichi Sankyo and Lilly Respond to Speculation on Status of Prasugrel New Drug Application
2. Lilly and Deciphera Pharmaceuticals Announce Licensing and Collaboration Agreement
3. Lilly Announces Initiation of Second Global Phase III Trial of Investigational Alzheimers Disease Compound
4. Insulin Analogues From Novo Nordisk, Eli Lilly and Sanofi-Aventis Will Drive Growth in the Type 1 Diabetes Drug Market
5. Phase II Data on Lillys Antibody Show It Affects Amyloid Beta, a Protein Believed To Be Associated with Alzheimers Disease
6. FDA Extends Review Period for Daiichi Sankyo, Lilly Investigative Antiplatelet Drug, Prasugrel
7. Lilly and TransPharma Medical Announce Licensing and Development Agreement
8. Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
9. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
10. Lilly Launches Its First Phase III Trial for Treatment of Alzheimers Disease
11. Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2015)... 2015  Olympus, a precision technology leader in designing ... among other core businesses, announced today the opening of ... Park, MN. The new medical device research ... the company for continued long-term growth in the surgical ... place on April 27 and was attended by ...
(Date:4/28/2015)... 28, 2015 Oramed Pharmaceuticals Inc. (NASDAQ: ... Shareholders and Associates, I am very excited to ... much-awaited Phase IIb clinical trial for oral insulin (ORMD-0801) and ... commence the trial in the coming weeks. This clinical trial will ... marks a significant milestone for the company, literally putting us ...
(Date:4/28/2015)... Minn. , April 28, 2015 ANI ... the Company plans to release its first quarter 2015 ... opening of the U.S. financial markets. The earnings press ... of the Company,s website, www.anipharmaceuticals.com . ... Executive Officer, and Charlotte C. Arnold , Vice ...
Breaking Medicine Technology:Olympus Opens New Surgical Innovation Center, Positioning Company for Long-term Growth 2Olympus Opens New Surgical Innovation Center, Positioning Company for Long-term Growth 3Olympus Opens New Surgical Innovation Center, Positioning Company for Long-term Growth 4Oramed Pharmaceuticals Inc. Issues Phase IIb Study Update Letter 2Oramed Pharmaceuticals Inc. Issues Phase IIb Study Update Letter 3ANI Pharmaceuticals Schedules Conference Call for First Quarter 2015 Financial Results 2
(Date:4/28/2015)... New York (PRWEB) April 28, 2015 ... http://www.xareltolawsuit2015.com/ ) are moving forward nationwide, as courts ... convene conferences next month. According to court documents ... of Louisiana, the next status conference in the ... 13th at 9:00 a.m. C.S.T. (In Re: ...
(Date:4/28/2015)... 2015 April 8th, 2015, saw ... “RockNRolla Movie Awards” EcoLuxe Lounge, with Choices Recovery ... Entertainment, Los Angeles’ leading producer of sustainable product ... force behind this event, which featured some of ... conscious products and services. The EcoLuxe Lounge is ...
(Date:4/28/2015)... April 28, 2015 A special 40th ... Thursday, April 16 in honor of the first performance ... Newman Theater 40 years ago. Michael Serrecchia, KD Conservatory’s ... as one of the original cast members of A ... cast of the critically-acclaimed musical Hamilton, currently playing on ...
(Date:4/28/2015)... Diego, CA (PRWEB) April 28, 2015 ... destination located at Omni La Costa Resort and Spa ... platform for continued weight loss and overall health at ... access to health coaches, PFC RevUp ensures the healthy ... when the pressures of life kick in and  clients are left to ...
(Date:4/28/2015)... 28, 2015 Helping Families and Friends ... a loved one dies can be overwhelming. For family ... arrangements and final tribute can be downright daunting. ... Beinhauer Family Funeral Homes knows this firsthand ... families by doubling its number of certified celebrants. Recently ...
Breaking Medicine News(10 mins):Health News:Xarelto Lawsuits Move Forward Nationwide, with Scheduling of May Conferences in Federal, State Litigations 2Health News:Xarelto Lawsuits Move Forward Nationwide, with Scheduling of May Conferences in Federal, State Litigations 3Health News:Choices Recovery South Bend Examines Support Systems in Treatment with Hollywood's Mike Pericoloso 2Health News:Michael Serrecchia, KD Musical Theatre Chair, Returns from NY from a 40th Reunion of Broadway’s Hit, A Chorus Line 2Health News:PFC Fitness Camp Launches Bullet-Proof Accountability Platform for Sustained Weight Loss At Home 2Health News:PFC Fitness Camp Launches Bullet-Proof Accountability Platform for Sustained Weight Loss At Home 3Health News:Beinhauer's Increasing Number of Celebrants to Meet Growing Demand for Personalized Funeral Ceremonies 2
... ... Swine Flu , ... (PRWEB) October 21, 2009 – As British Columbians face another wave of H1N1 this fall, ... and preventative tips in order to reduce the impact on campus life., , , , ...
... Not Enough Evidence Yet to Support Minimally Invasive ... Symptoms, Say Researchers in Journal of Vascular and Interventional Radiology ... risk of peripheral arterial disease (or PAD) -- with healthy ... in a recent issue of the Journal of Vascular and ...
... 21 A new tasty citrus-flavored vitamin drink is now ... help give immune systems a healthy boost* this Fall. , ... fun, healthy and convenient way to get a concentrated boost ... comprised of the original Emergen-C (®) ( )formula, ...
... helping thousands of patients get their lives back through minimally ... and soon Philadelphia, the Laser Spine Institute (LSI) ... (ABB) , extending LSI,s patient care capabilities ... led by visionary entrepreneur Clint Phillips, CSCS, ABB is a ...
... Wisconsin has been awarded a five-year, $8 million, multi-investigator Program ... understand how human pluripotent stem cells, defined as cells which ... of the more than 200 cell types in the human ... , "To date no one has been able to replace ...
... benefit from more aggressive treatment, study finds , WEDNESDAY, ... skin does a better job of removing wrinkles and ... University of Michigan researchers report. , Known as microdermabrasion, ... the appearance of wrinkles, acne scars, skin discoloration and ...
Cached Medicine News:Health News:UCW Academy of Health Preps to Combat Spread of H1N1 2Health News:Lifestyle Changes Remain Important in Fighting Peripheral Arterial Disease (PAD) 2Health News:Lifestyle Changes Remain Important in Fighting Peripheral Arterial Disease (PAD) 3Health News:Lifestyle Changes Remain Important in Fighting Peripheral Arterial Disease (PAD) 4Health News:Lifestyle Changes Remain Important in Fighting Peripheral Arterial Disease (PAD) 5Health News:New Quick and Convenient Emergen-C(R) Shot Gives Immune Systems a Fighting Chance This Fall 2Health News:New Quick and Convenient Emergen-C(R) Shot Gives Immune Systems a Fighting Chance This Fall 3Health News:Leaders in Minimally Invasive Spinal Surgery Acquire Non-Surgical Spine Therapy Pioneer 2Health News:$8 million NIH grant for heart cell development and study 2Health News:With Microdermabrasion, Rough Seems to Work Better 2Health News:With Microdermabrasion, Rough Seems to Work Better 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: